ADJUVANT CHEMOTHERAPY IN OPERABLE GASTRIC CANCER: 5 Year Follow-up of First British Stomach Cancer Group Trial
- 18 March 1989
- journal article
- clinical trial
- Published by Elsevier BV in The Lancet
- Vol. 333 (8638), 571-574
- https://doi.org/10.1016/s0140-6736(89)91607-3
Abstract
No abstract availableThis publication has 10 references indexed in Scilit:
- Programme for early detection of gastric cancer.BMJ, 1986
- Resection line disease in stomach cancer. British Stomach Cancer Group.BMJ, 1984
- An interim report of a prospective, randomized, controlled study of adjuvant chemotherapy in operable gastric cancer: British stomach cancer groupWorld Journal of Surgery, 1983
- MITOMYCIN-INDUCED HAEMOLYSIS AND RENAL FAILUREThe Lancet, 1980
- INTRAVASCULAR HÆMOLYSIS AND RENAL IMPAIRMENT AFTER BLOOD TRANSFUSION IN TWO PATIENTS ON LONG-TERM 5-FLUOROURACIL AND MITOMYCIN-CThe Lancet, 1980
- Review of Consecutive Ten Year IntervalsAnnals of Surgery, 1979
- Surgical adjuvant chemotherapy.Results with one short course with cyclophosphamide after mastectomy for breast cancerCancer, 1978
- Results of surgery for gastric cancer and effect of adjuvant mitomycin C on cancer recurrenceWorld Journal of Surgery, 1977
- The Use of Triethylenethiophosphoramide as an Adjuvant to the Surgical Treatment of Gastric CarcinomaAnnals of Surgery, 1968
- Use of thio-TEPA as an adjuvant to the surgical management of carcinoma of the stomachCancer, 1965